Although respiratory infections and diseases are stated as contraindications for HBOT, the situation of SARS-CoV-2 is surely an exception. Nowadays, the probable utilization of HBOT in the COVID-19 has long been specifically regarded, exposing ends in numerous controlled scientific trials. Moreover, the usage of this treatment in numerous types of